🔴 Did you miss our latest webinar? If you skipped our latest conversation on the intersection of #AI and radiomics in biopharma, don't worry! The recording is now available so you can catch up on all the discussions and innovative ideas shared by our top-notch speakers. 💻 Ideal for researchers, scientists, and professionals in the biopharmaceutical, technology, and medical fields looking to stay current in this rapidly changing landscape, the transformative impact of AI was highlighted through case studies and success stories shared by our panel of experts. Take advantage of this chance to access the valuable insights shared during the live event! https://bit.ly/47S8v6b Pamod Hemakumara Fuensanta Bellvís Bataller Ronald Korn
So proud and happy to be finalists of the Spanish Chamber of Commerce in the United Kingdom's inaugural PREMIO PYME! 🎉
❄ We recently attended the 'Journées d'Hiver de la Société d'Imagerie Génito-Urinaire (SIGU) 2024', organized by the Société Française de Radiologie et d'imagerie médicale (SFR). It was amazing to interact with the French Genito-Urinary Imaging Society, exchanging views, and collaborating with subject matter experts, we showcased our cutting-edge imaging and #prostate solutions. Special thanks to Philippe PUECH, Raphaële Renard Penna , carole delerue and Patricia Gutierrez for their organization. Stay tuned for updates from this event in the heart of the French Alps! #MedicalImaging #PrecisionHealth
Exciting news! We are proud to announce our strategic collaboration with Merck KGaA, Darmstadt, Germany to advance #PrecisionMedicine through AI-powered radiomics solutions. 🌍 Global challenge: Efficient clinical development for #cancer is a critical challenge globally, given the increasing number of patients needing personalized treatment. According to the Global Cancer Observatory, with cancer cases expected to reach 30 million new cases each year by 2040, our mission is to reduce costs and timelines in drug development programs. 🎯 Precise solution: Our #AI expertise creates predictive models, optimizing patient stratification and characterization and understanding the potential benefits of novel therapies. Merck intends to integrate these models into its global drug development and commercialization strategies, fostering #data-driven decision-making. Read everything about it https://bit.ly/3OioIdQ and stay tuned for updates as we further transform #cancercare.
🚀 At the vanguard of innovation our CEO, Dr.Ángel Alberich-Bayarri, participated this morning in the latest #TechTrends 2024, organized by Globant and Business Insider España. The conference has delved into fundamental and relevant topics such as #AI or quantum computing, areas that are changing industries and driving transformational changes. Discussions like this truly underscore our commitment to staying ahead of the curve, embracing emerging technologies and contributing to the global dialogue on #innovation. It was a great opportunity to network with thought leaders, industry experts and visionaries conducting change in the technology landscape.
🎉 Proud to be on the Tech Tour Growth50 List! With great enthusiasm, we announce our selection for the Tech Tour Growth50 list! Being recognized as a potential future European unicorn highlights our commitment to transforming the #healthcare sector. This recognition signifies more than growth—it reflects our dedication to developing innovative solutions for real-world problems. As one of Europe's leading #technology innovators, we are more motivated than ever to continue innovating, exploring new frontiers, and leading the way to a better future. We look forward to engaging with prominent growth investors and pioneering entrepreneurs at the Tech Tour Growth50 Europe Summit in Paris on February 8 👉 https://lnkd.in/dVpyrAX5 We sincerely thank Tech Tour and our amazing community for your support! 🙌
We are proud to announce a major milestone in our AI-based tool, QP-Prostate, as the updated product has been granted CE and UKCA marks and is now equipped with world-class #cancer detection capabilities, enabling clinicians in the EU and UK to harness its power. Some of its key features include: - 🚀 Increased efficiency: Addressing imaging overload in #radiology departments, QP-Prostate speeds up image processing, improves radiologists' accuracy, and streamlines #data transfer to oncology departments. - 🎯 High performance: Backed by a validated study, QP-Prostate achieves 88% accuracy in #prostate image segmentation, volume calculation and biopsy planning assistance. - 🧠 Innovative lesion detection: Our solution introduces #AI-driven lesion detection trained with post-biopsy pathology data for greater accuracy and faster reporting. 🌐 With over 150+ global sites, read everything about it here and stay tuned for updates! https://bit.ly/3HrsP3D
🌟 We're participating in the European Federation for Cancer Images (EUCAIM) consortium meeting in Valencia, Spain! Initiatives like EUCAIM are completely changing #cancercare. With EUR 36 million in funding, more than 50 #AI algorithms and the goal of unifying dispersed cancer imaging datasets across Europe to create an open, easy-to-use infrastructure, #precisionmedicine can undergo a major shift. By integrating QP-Insights® into the Central Atlas, we ensure hashtag#data reliability and patient privacy. The commitment to GDPR compliance and expertise in data de-identification is critical. 🚀 We are pioneers in early disease detection, and through collaborations we improve treatment possibilities and set new standards together. Read everything about it here https://bit.ly/3vKYVVc
⏳ Only a few days left! Secure your place for our next webinar hosted by Xtalks "AI and radiomics in drug development: Challenges and approaches". https://bit.ly/3vf9e3z 🗓️ Next Monday, January 22 🕝 2pm EST (11am PST) 🗣️Speakers: Ronald Korn Founder and Medical Director, Imaging Endpoints Pamod Hemakumara Director of Corporate Development, Quibim Fuensanta Bellvís Bataller VP of Clinical Studies, Quibim 🔎Join this event to gain a deeper understanding of how #AI and #radiomics are transforming #drugdevelopment, from high-level insights to real-world applications.
🌐 On January 26, our CEO Ángel Alberich-Bayarri will participate in the Basel Healthtech Conference organized by MTIP and Stifel Financial Corp. To share ideas and gain valuable insights, join us and delve into this event that uncovers transformative #healthcare technology solutions and insights. 🤝 This is the perfect opportunity to connect and contribute to the advancement of #patientcare. Save the date! #BHT2024
